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        Introduction 
  The IGF-1 (insulin growth factor 1)  –  PI3K (phosphatidylino-
sitol 3-kinase)  –  Akt pathway plays a crucial role in a broad 
range of biological processes involved in the modulation of 
local responses as well as processes implicated in metabolism, 
cell proliferation, transcription, translation, apoptosis, and 
growth. In the heart, the IGF-1  –  PI3K  –  Akt pathway is involved 
in the regulation of contractile function, and impairment of this 
signaling pathway is considered an important determinant of 
cardiac function (  Condorelli et al., 2002  ;   McMullen et al., 
2003  ;   Ceci et al., 2004  ;   McMullen et al., 2004  ;   Catalucci and 
Condorelli, 2006  ;   Sun et al., 2006  ). 
  The Akt (also called PKB) family of Ser/Thr kinases con-
sists of three isoforms (Akt-1, -2, and -3) that are activated by 
IGF-1 and insulin through PI3K, which is a member of the 
lipid kinase family involved in the phosphorylation of mem-
brane phosphoinositides (  Ceci et al., 2004  ). The product of 
PI3K binds to the pleckstrin domain of Akt and induces 
its translocation from the cytosol to the plasma membrane, 
where Akt becomes accessible for phosphorylation by PDK1 
(phosphoinositide-dependent kinase 1), resulting in its activa-
tion (  Ceci et al., 2004  ;   Bayascas et al., 2008  ). The Ca 
2+   current 
(I  Ca,L  ) in both cardiomyocytes and neuronal cells has been 
shown to be increased by Akt activation (  Blair et al., 1999  ;   
Viard et al., 2004  ;   Catalucci and Condorelli, 2006  ;   Sun et al., 
2006  ) and decreased by Akt inhibition (  Viard et al., 2004  ; 
  Catalucci and Condorelli, 2006  ;   Sun et al., 2006  ), suggesting a 
pivotal role of Akt in regulating L-type Ca 
2+   channel  (LTCC) 
complex function. 
T
he insulin IGF-1  –  PI3K  –  Akt signaling pathway has 
been suggested to improve cardiac inotropism and 
increase Ca 
2+   handling through the effects of the 
protein kinase Akt. However, the underlying molecular 
mechanisms remain largely unknown. In this study, we 
provide evidence for an unanticipated regulatory func-
tion of Akt controlling L-type Ca 
2+   channel (LTCC) pro-
tein density. The pore-forming channel subunit Ca  v      1 
contains highly conserved PEST sequences (signals for 
rapid protein degradation), and in-frame deletion of 
these PEST sequences results in increased Ca  v      1 protein 
levels. Our ﬁ   ndings show that Akt-dependent phosphory-
lation of Ca  v      2, the LTCC chaperone for Ca  v      1, antag-
onizes Ca  v      1 protein degradation by preventing Ca  v      1 
PEST sequence recognition, leading to increased LTCC 
density and the consequent modulation of Ca 
2+   channel 
function. This novel mechanism by which Akt modulates 
LTCC stability could profoundly inﬂ  uence cardiac myo-
cyte Ca 
2+   entry, Ca 
2+   handling, and contractility.
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deletion of PDK1 in the adult heart. A further advantage of this 
model is the inducible cardiac-specifi  c deletion that was neces-
sary to circumvent the embryonic lethality we observed in a 
mouse model with constitutive    -MHC – Cre  cardiac  deletion 
of PDK1 (unpublished data). Similar to the muscle creatine 
kinase  –  Cre PDK1 mouse model (  Lawlor et al., 2002  ), PDK1 
gene deletion in the adult mouse heart (KO;   Fig. S1, A and B  ) 
resulted in a lethal phenotype with a mortality that reached 
100% at 10 d after tamoxifen injection (Fig. S1 C). Age-
matched littermate control mice without   cre   (wild type [WT]) 
were unaffected by tamoxifen treatment. Consistent with fi  nd-
ings from the previously reported analysis of the PDK1 KO 
mouse model (  Lawlor et al., 2002  ), cardiac function evaluated 
by echocardiography at 7 d after tamoxifen injection revealed 
dramatically impaired systolic function with severe dilated 
cardio  myopathy and an abrupt drop in fractional shortening in 
KO but not in WT mice (Fig. S1 D,   Table S1  , and not depicted). 
Histological examination substantiated the echocardio  graphic 
fi  ndings, revealing dilatation of both ventricles and atria (Fig. S1 E) 
with apparently no evidence of signifi  cant apoptosis or inter-
stitial fi  brosis (Fig. S1, F and G). These observations indicate 
that PDK1/Akt activity plays a major role in maintaining adult 
heart function. 
  Deﬁ  ciency in Akt activity leads to a 
reduction in the Ca  v      1 protein level 
  Using the cardiac-specifi  c PDK1 KO mouse model, we investi-
gated whether defi  ciency in Akt activity affects the expression 
or activation of signaling molecules that are implicated in Ca 
2+  
handling and cardiac function. A time course analysis of ex-
tracts from WT and KO mouse ventricles revealed striking 
changes in protein expression upon induction of the PDK1 KO 
(  Fig. 1, A and B  ). Notably, KO mice had decreased protein lev-
els of the pore-forming Ca 
2+   channel subunit, Ca  v    1, which pro-
gressed as PDK1 protein expression gradually declined. No 
change in the protein level of the regulatory Ca  v   2  subunit  was 
observed. As PDK1 expression decayed, levels of Akt activa-
tion also dramatically decreased (assessed by phosphorylation 
of Akt at the PDK1 phosphorylation site Thr308) despite un-
altered expression of total Akt protein (  Fig. 1, A and B  ). Further-
more, Akt activity (assessed using GSK-3     as a substrate) was 
virtually absent in KO hearts (  Fig. 1 C  ). Based on this evidence, 
we decided to perform further experiments at day 6 after the be-
ginning of treatment. 
  Although the main physiological action of PDK1 is on 
Akt activation, PDK1 can potentially infl  uence other members 
of the cAMP-dependent, cGMP-dependent, and PKC (AGC) 
kinase protein family such as PKC and PKA, which could also 
affect cellular Ca 
2+   handling (  Williams et al., 2000  ;   Mora et al., 
2004 ). However, PKC activity was unchanged in KO mice (1.15  ±  
0.05  –  fold greater than WT; not statistically signifi  cant; as-
sessed by an assay using a PKC-specifi  c peptide as substrate). 
There was no apparent effect of PDK1 deletion on SERCA2a 
(  Fig. S2 A  ) as well as PKA activity because the phosphorylation 
of specifi  c PKA regulatory sites in two SR Ca 
2+   regulatory  pro-
teins, Ryr (Ryr2-P2809) and phospholamban (PLN; PLN-P16), 
were unchanged in KO mice (Fig. S2 B), although it cannot be 
  In cardiomyocytes, the LTCC is composed of different 
subunits: the pore-forming subunit Ca  v    1 and the accessory   
   and    2    subunits  ( Catterall,  2000 ;   Bourinet  et  al.,  2004 ). 
The opening of the LTCC is primarily regulated by the mem-
brane potential and by other factors, including a variety of 
hormones, protein kinases, phosphatases, and accessory pro-
teins (  Bodi et al., 2005  ). In healthy cardiomyocytes, electrical 
excitation starting during the upstroke of the action potential 
leads to cytosolic Ca 
2+   infl  ux through opening of the LTCC 
(  Bers and Perez-Reyes, 1999  ;   Richard et al., 2006  ). This trig-
gers the CICR (Ca-induced Ca release) of intracellular Ca 
2+  
from the sarcoplasmic reticulum (SR) through activation of 
the ryanodine receptor (Ryr), eventually leading to cardio-
myocyte contraction (  Bers, 2002  ). 
  The importance and ubiquity of Ca 
2+   as an intracellular 
signaling molecule suggests that altered channel function could 
give rise to widespread cellular and organ defects. Indeed, a 
variety of cardiovascular diseases, including atrial fi  brillation, 
heart failure, ischemic heart disease, Timothy syndrome, and 
diabetic cardiomyopathy, have been related to alterations in the 
density or function of the LTCC (  Mukherjee and Spinale, 1998  ; 
  Quignard et al., 2001  ;   Bodi et al., 2005  ;   Pereira et al., 2006  ). 
However, the molecular basis for dysregulation of LTCC func-
tion and the possible involvement of Akt in I  Ca,L   regulation re-
main unresolved. 
  Recently, a seminal study in neuronal cells revealed the 
importance of Akt-dependent phosphorylation of the Ca  v   2  sub-
unit in promoting the chaperoning of the Ca  v 2.2  pore-forming 
unit to the plasma membrane (  Viard et al., 2004  ). In this study, 
we identify a novel posttranslational mechanism by which Akt 
modulates LTCC function under physiological conditions, 
highlighting the pivotal role of this kinase in cardiac function. 
Interestingly, our results show that the pore-forming channel 
subunit Ca  v    1 contains highly conserved PEST sequences 
that direct rapid protein degradation and demonstrate that 
Akt-mediated phosphorylation of the Ca  v   2  LTCC  chaperone 
subunit prevents PEST site recognition, thereby slowing or 
preventing Ca  v    1 degradation. This mechanism of action 
might be an essential process for Ca 
2+   channel functional reg-
ulation, thus contributing to normal or better cardiomyocyte 
contractile function. 
  Results 
  To gain insight into the mechanism of action by which Akt regu-
lates I  Ca,L   and Ca 
2+   handling in the heart, we studied a mouse line 
with tamoxifen-inducible (  Sohal et al., 2001  ) and cardiac-
specifi  c deletion of PDK1, the upstream activator of all three Akt 
isoforms. Mice in which exons 3 and 4 of the   pdk1   gene were 
fl  anked by   loxP   excision sequences (  Lawlor et al., 2002  ) were 
crossed with transgenic (Tg) mice expressing an inducible and 
cardiac-specifi  c MerCreMer     -MHC promoter driving the   cre  
recombinase gene (  Sohal et al., 2001  ), resulting in MerCreMer 
    -MHC PDK1 mice (knockout [KO]). As opposed to the pre-
viously described muscle creatine kinase  –  Cre PDK1 mouse 
model (  Mora et al., 2003  ) in which PDK1 is embryonically 
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WT cells (  n   = 12; P   <   0.001). In addition, there was no signifi  -
cant difference in either steady-state activation or inactivation 
curves (unpublished data). Indeed, mean half-activation occu  r  red 
at     12.97   ±   0.53 mV in WT cells versus     15.07   ±   0.66 mV 
in KO cells, and mean half-inactivation occurred at    31.11   ±  
0.48 mV in WT cells versus     30.77   ±   0.42 mV in KO cells. 
The absence of a shift in the voltage dependence of these prop-
erties (  Fig. 2 B  ) was consistent with the absence of modifi  cation 
in gating properties of the LTCC, suggesting that a reduction in 
the number of functional LTCCs can account for the observed 
decrease in I  Ca,L   in KO mice. Of note, the decay kinetics of I  Ca,L  
were slower in KO cells compared with WT cells with a de-
crease in the early fast inactivating component (  Fig. 2 A  ). Con-
sistent with previous observations by us and others regarding 
the role of Akt in cardiac function (  Blair et al., 1999  ;   Condorelli 
et al., 2002  ;   Kim et al., 2003  ;   Sun et al., 2006  ), both contraction 
(  Fig. 2 C  ) and systolic Ca 
2+   amplitudes (Ca 
2+   transients;   Fig. 2 D   
and   Fig. S3 A  ) were signifi  cantly depressed (by    35%  and 
30%, respectively; P   <   0.05) in KO cardiomyocytes compared 
with WT littermates. 
  The observed reduction in Ca 
2+   transient amplitude and 
cardiac contractility could be explained by reduced Ca 
2+   entry 
into cells via the LTCC, but decreased intracellular Ca 
2+   release 
from the SR may also contribute. However, although the Ca 
2+  
transient amplitude between the systolic and diastolic phase 
(twitch) was smaller in KO cardiomyocytes (Fig. S3 B, left bars), 
no difference in total SR Ca 
2+  content was found (Fig. S3 B, right 
bars), suggesting that the decrease in Ca 
2+   transient amplitude is 
only caused by reduced Ca 
2+   entry. This is consistent with the 
observed slowing of the early fast inactivation of I  Ca,L   ( Fig.  2 A ), 
which is highly dependent on CICR-triggered SR Ca 
2+   release 
during the action potential (  Richard et al., 2006  ). Therefore, we 
conclude that the reduced I  Ca,L   may contribute to the reduced 
contractility in KO hearts. 
  Akt regulates the Ca  v      1 protein level at 
the plasma membrane 
  The properties of the Ca  v    1 subunit are known to be markedly 
affected by LTCC accessory subunits (  Catterall, 2000  ;   Bourinet 
et al., 2004  ). Among the LTCC accessory subunits expressed in 
the heart, Ca  v    2 is known to act as a chaperone for the Ca  v   1 
subunit, both as a positive modulator of channel opening proba-
bility and for its traffi  cking from the ER to the plasma membrane 
( Yamaguchi et al., 1998 ;  Viard et al., 2004 ). Therefore, supported 
by previous results (  Viard et al., 2004  ) as well as corroborated by 
unchanged Ca  v   1 mRNA levels in KO compared with WT hearts 
(  Fig. 3 A  ), we hypothesized that in the heart, an Akt-mediated 
phosphorylation of the LTCC accessory subunit would mainly 
affect traffi  cking of Ca  v   1 protein to the plasma membrane. How-
ever, because the amount of Ca  v    1 was reduced in both micro-
somal and membrane fractions from KO extracts compared 
with WT (  Fig. 3 B  ), we hypothesized that the reduced Ca  v   1 
level observed in KO mice was caused by enhanced protein deg-
radation in addition to impaired protein translocation to the 
plasma membrane. To assess the pathway involved in the Akt-
dependent Ca  v    1 protein degradation, three sets of specifi  c cell 
degradation system inhibitors were examined for their ability to 
excluded that typical changes associated with heart failure and 
secondary to adrenergic receptor hyperactivation may take place 
at subsequent time points. Collectively, these data suggest that 
an acute reduction in Akt activation affects expression of pro-
teins involved in the Ca 
2+   infl  ux into the cell. 
  Deﬁ  ciency in Akt activity affects I  Ca,L   
 Ca 
2+   handling and inotropism were examined in adult cardio-
myocytes freshly isolated from WT and KO mice. Using the 
whole cell voltage-clamp technique, we recorded and analyzed 
LTCC I  Ca,L   properties. No difference in cell size was observed 
between WT and KO cells as deduced from membrane capaci-
tance measurements. Membrane capacitance was 116   ±   6 pF in 
WT cells (  n   = 18) and 115   ±   6 pF in KO cells (  n   = 18). However, 
the density of I  Ca,L   (picoampere/picofarad) was decreased in KO 
versus WT (  Fig. 2 B  ). At 0 mV, the density of I  Ca,L   was    9.08   ±  
0.96 pA/pF in KO cells (  n   = 12) versus     16.26   ±   0.96 pA/pF in 
  Figure 1.       Alteration of Ca 
2+   handling proteins in PDK1 KO cardiomyo-
cytes.   (A and B) Western blot (A) and densitometric (B) analyses of ven-
tricular homogenates along a time course of tamoxifen inductions (day 
1  –  6 treatment is indicated by the line in A) using various antibodies. 
A representative experiment is shown (  n   = 3). Error bars show SD. (C) Total 
Akt activity in WT and KO cardiomyocyte lysates assayed using a GSK-
3    /     Akt-speciﬁ  c substrate. IP, immunoprecipitation.     JCB • VOLUME 184 • NUMBER 6 • 2009  926
tection effect was abolished in the absence of Ca  v   2  cotransfec-
tion, a condition under which Ca  v   1 is retained in the ER ( Fig. 3 C , 
bottom). All together, these results confi  rm that Akt activity is 
regulating Ca  v   1 protein density and reveal that in the absence of 
Akt function, Ca  v    1 is susceptible to lysosome-mediated mem-
brane protein degradation. 
 Because  Ca v    2 is the only LTCC accessory subunit con-
taining an Akt phosphorylation consensus site (  Viard et al., 
2004  ), we hypothesized that Ca  v    1 protein degradation at the 
plasma membrane might result from loss of Ca  v   2  chaperone  ac-
tivity in the absence of Akt-induced phosphorylation. In support 
prevent the decrease in Ca  v    1 protein elicited by Akt inhibi-
tion. Treatment of Ca  v    1- and Ca  v    2-cotransfected cells with 
bafi  lomycin-A1, an inhibitor of the lysosomal degradation sys-
tem responsible for the degradation of many membrane proteins 
(  Dice, 1987  ), prevented the decrease in Ca  v    1 protein induced by 
Akt inhibition (  Fig. 3 C  , top). Conversely, a ubiquitin/proteasome 
inhibitor, MG132, failed to protect Ca  v    1 from protein degrada-
tion. Similar results were obtained by inhibiting calpain, the 
intracellular Ca 
2+  -dependent Cys protease known to be involved 
in membrane protein degradation (  Belles et al., 1988  ;   Romanin 
et al., 1991  ). Intriguingly, the bafi   lomycin-A1 – dependent  pro-
  Figure 2.       Impaired intracellular Ca 
2+   handling and 
contractility in PDK1 KO cardiomyocytes.   (A and B) 
Smaller Ca 
2+   current in KO cardiomyocytes. (A) Whole 
cell representative I  Ca,L   currents normalized for differ-
ence in cell size. (B) I  Ca,L   I-V current/voltage relationships 
(  n   = 12; *, P   <   0.05; **, P   <   0.01). (C and D) Cardio-
myocyte contraction and Ca 
2+   transients at different 
stimulation frequencies. (C) Cardiomyocyte shorten-
ing is decreased in KO compared with WT cardio-
myocytes (*, P   <   0.05; ANOVA). (D) Ca 
2+   frequency 
relationship indicates smaller peak systolic but not dia-
stolic Ca 
2+   in KO compared with WT cells (*, P   <   0.05; 
ANOVA). Error bars show SEM.     
  Figure 3.       Akt mediates regulation of Ca  v      1 protein density at the plasma membrane.   (A) RT-PCR analysis of Ca  v      1 mRNA expression from WT and KO 
ventricular extracts. GAPDH served as a loading control. (B) Western blot analysis of whole lysate, membrane, and microsomal fractions from WT and 
KO ventricular extracts. CSQ, calsequestrin. (C) YFP-Ca  v      1  –  transfected COS-7 cells alone or in combination with Ca  v      2 expression vector were serum 
starved and treated with Akt inhibitor (Akt inh.) and 1   μ  M baﬁ  lomycin-A1, 25   μ  M MG132, or 25   μ  M calpeptin. 6 h after drug administration, cell lysates 
were prepared and subjected to Western blot analysis for YFP. GAPDH served as a loading control. (D and E) Ca  v      1 protein levels in KO cardiomyocytes 
infected with empty (mock) or active E40K-Akt (AdAkt)  –  expressing adenoviral vector (D) and in whole lysates of WT and E40K-Akt (Tg Akt) hearts (E). 
Representative experiments are shown (  n   = 4).     927 AKT REGULATES THE CA
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Collectively, these data demonstrate that active Akt binds to and 
phosphorylates Ca  v    2, the chaperone for Ca  v   1. 
  To directly assess whether Akt phosphorylation of Ca  v   2 
protects Ca  v    1 from protein degradation, we constructed a mu-
tant of Ca  v    2 in which Ser625, which is contained in the putative 
Akt consensus site (R-X-X-R-S/T), was replaced by glutamate 
(Ca  v    2-SE) to mimic phosphorylation. Cotransfection of 293T 
cells with Ca  v   1  and  Ca v    2-SE resulted in Ca  v    1 protein levels 
that were increased compared with those found when cotrans-
fected with Ca  v    2-WT (  Fig. 5 A  ). Similarly, Ca  v   1  expression 
was increased in insulin-treated Ca  v   2-WT – cotransfected  cells 
(  Fig. 5 A  ). Notably, the active phosphomimic Ca  v   2-SE  also 
counteracted the down-regulation of Ca  v    1 induced by an Akt in-
hibitor (  Fig. 5 B  ). Opposite results were obtained with a dominant-
negative (DN) Ca  v    2 mutant in which Ser was replaced by 
Ala (Ca  v    2-SA) to prevent Akt phosphorylation. Indeed, Ca  v   1 
protein levels were reduced when coexpressed with Ca  v   2-SA 
(  Fig. 5 C  ). In addition, insulin stimulation failed to increase 
Ca  v    1 in the presence of the DN Ca  v    2-SA mutant (  Fig. 5 C  ). 
Consistent with the hypothesis that Ca  v    1 protein down-
regulation relies on Akt kinase activity, overexpression of a DN 
form of Akt (AdAktDN) resulted in a signifi  cant reduction in 
Ca  v    1 protein levels, whereas forced expression of AdAkt was 
suffi  cient to counteract Ca  v    1 reduction in a serum-free condi-
tion, in which Akt is not phosphorylated (Fig. S4 B). Further-
more, suppression of Akt expression in 293T cells by siRNA 
(small interfering Akt [siAkt]) resulted in reduction of the Ca  v   1 
protein level (  Fig. 5 D  ). 
  To support the evidence that Akt-dependent phosphory-
lation of Ca  v    2 is a determinant for Ca  v    1 stability and func-
tionality, we measured the effect of the Ca  v    2 mutants on Ca 
2+  
current. Although cotransfection of cells with Ca  v   1  and 
Ca  v    2-WT resulted in signifi  cant depressed I  Ca,L   in  serum-free 
medium compared with serum-containing medium in which 
Akt is phosphorylated (not depicted), cotransfection of Ca  v   1 
of this hypothesis, forced expression of the active E40K-Akt 
  mutant (AdAkt) restored Ca  v    1 protein levels in isolated cardio-
myocytes from KO mice (  Fig. 3 D  ). Similarly, cardiomyocytes 
from Tg mice expressing constitutively active HA  –  E40K-Akt 
(Tg Akt;   Condorelli et al., 2002  ) showed increased Ca  v   1  levels 
compared with WT controls (  Fig. 3 E  ). 
  Akt is a determinant for Ca  v      1 protein 
level regulation by direct phosphorylation 
of the Ca  v      2 chaperone subunit 
  To assess whether Akt is directly involved in modulation of 
Ca  v    2 chaperone activity in the heart, we fi  rst confi  rmed the in-
teraction between Akt and Ca  v    2. Ventricular homogenates de-
rived from either WT or Tg Akt mice were immunoprecipitated 
with anti-HA antibody and assayed for Ca  v    2, which revealed 
association of the Ca  v    2 subunit with active Akt (  Fig. 4 A  ). 
Similarly, Ca  v    2 was found to coimmunoprecipitate with insulin-
stimulated endogenous Akts (  Fig. S4 A  ). 
  To determine whether Ca  v    2 can be phosphorylated by 
Akt, Ca  v    2 immunoprecipitates from cardiac homogenates 
were incubated with recombinant active Akt and    -[ 
32 P]ATP. 
A band corresponding to phosphorylated Ca  v    2 was detected only 
in the presence of the kinase (  Fig. 4 B  , left). To determine 
whether the Ca  v    2 subunit was phosphorylated by Akt in vivo, 
we treated overnight-starved mice with 1 mU/g insulin to in-
duce activation of Akt (  Bayascas et al., 2008  ). 20 min after 
treatment, Ca  v    2 was immunoprecipitated from ventricular 
homo  genates, subjected to Western blot analysis, and probed for 
phosphorylated Akt consensus sites using phospho-Akt sub-
strate antibody. This revealed insulin-stimulated phosphory-
lation of Ca  v    2 in WT but not in KO hearts (  Fig. 4 B  , right). 
Furthermore, a back phosphorylation assay, which is used to as-
sess the basal state of Ca  v    2 phosphorylation, revealed a reduc-
tion of the basal phosphorylation level of Ca  v    2 by 36% (P   <   
0.05) in KO mouse ventricle compared with WT (  Fig. 4 C  ). 
  Figure 4.       Akt interacts with and phosphorylates Ca  v      2.   
(A) Coimmunoprecipitation assay of Akt and Ca  v      2. Ven-
tricular homogenates from WT and HA  –  E40K-Akt Tg mice 
(Tg Akt) immunoprecipitated with antibodies against HA 
and immunoblotted for Ca  v      2 as well as HA as a con-
trol. (B) Examination of Ca  v      2 phosphorylation by Akt. In 
vitro kinase assays were performed with immunoprecipi-
tated Ca  v      2 incubated with recombinant active Akt and   
32  P-labeled ATP (left) or immunoprecipitated Ca  v      2 from WT 
and KO cardiac extracts from mice treated or not treated 
with 1 mU/g insulin using phospho-Akt substrate (PAS) 
anti  body (right). (C) Back phosphorylation assay of Ca  v      2 
from WT and KO hearts. Immunoprecipitated Ca  v      2 from 
solubilized membranes was in vitro back phosphory-
lated using recombinant active Akt and [     
32  ]ATP. Pre-
cipitate amounts were assayed for [ 
32  P]Ca  v      2 and total 
Ca  v      2. Representative experiments are shown (  n   = 4). 
IP, immunoprecipitation.     JCB • VOLUME 184 • NUMBER 6 • 2009  928
mary binding region for Ca  v    2 (  Fig. 7 A  ;   Bodi et al., 2005  ). To 
determine whether these PEST sequences are involved in Ca  v   1 
degradation control, we generated two in-frame deletion mutants 
encompassing either the I  –  II (Ca  v   1-  P)  or  II – III  (Ca v   1-  H) 
cytosolic linker region (  Fig. 7 A  ). Western blot and immunofl  uor-
escence analyses of serum-starved 293T cells transfected with 
these mutants revealed higher protein expression levels for both 
Ca  v   1-  P  and  Ca v   1-   H mutants compared with Ca  v   1-WT, 
which is consistent with the hypothesis that these motifs deter-
mine Ca  v    1 protein stability (  Fig. 7 B  ). Furthermore, a pulse-
chase analysis, with a chase starting 36 h after cell starvation, 
revealed markedly increased protein stability of Ca  v   1-  P  and 
Ca  v   1-   H compared with Ca  v    1-WT (  Fig. 7 C  ). In particular, 
Ca  v    1-WT showed a short half-life typical of proteins containing 
PEST sequences (  Dice, 1987  ), with a rapid and progressive deg-
radation starting 4 h after the chase and reaching 50% of degrada-
tion 25 h after the chase. In contrast, Ca  v   1-   P and Ca  v   1-  H 
mutants were less sensitive to degradation and were degraded by 
only 23% and 15% after 25 h, respectively (P   <   0.001). Notably, 
cotransfection of Ca  v    2-SE with Ca  v    1-WT resulted in a consid-
erable increase in the half-life of Ca  v    1-WT (  Fig. 7 C  ). In addi-
tion, transfection of 293T cells with Ca  v   1 PEST sequences fused 
in frame with GFP resulted in marked instability of GFP, as 
shown by both Western blot and immunofl  uorescence analyses 
(  Fig. 7 D  ), providing further evidence that these motifs are deter-
minants for Ca  v    1 protein stability. Consistent with the hy  po  th-
esis that Akt-mediated protection of Ca  v   1  degradation  acts 
through PEST sequences, overexpression of AdAktDN or siAkt 
had no signifi  cant effect on protein levels of either Ca  v   1-  P  or 
Ca  v   1-   H mutants (Fig. S4, B and C). To assess whether the ob-
served PEST mechanism is caused by a direct Akt-dependent in-
teraction between Ca  v    2 and Ca  v    1, we performed in vitro 
binding assays using in vitro  –  translated [ 
35 S]Met-labeled  Ca v   1 
cytosolic domains and a GST-fused Ca  v   2  C-terminal  coiled-coil 
region. Notably, direct interaction took place between the Akt-
phosphorylated Ca  v    2 C-terminal coiled-coil region and the 
Ca  v    1 C-terminal domain (  Fig. 7 E  ). No interactions were found 
with other Ca  v    1 cytosolic domains (unpublished data), although 
it cannot be excluded that other binding sites may exist. 
  To assess whether PEST-deleted Ca  v    1 channels are still 
functional, traffi  c appropriately to the membrane, and associate 
with the Ca  v    2 subunit, we measured Ca 
2+   current in Ca  v   1-  H 
mutant  –  transfected cells. No significant differences in I  Ca,L  
were found in cells transfected with Ca  v    1-WT compared with 
Ca  v   1-   H (  Fig. 7 F  ). Conversely, although serum deprivation 
resulted in I  Ca,L   reduction in Ca  v   1-WT – transfected  cells,  no  sig-
nifi  cant changes were observed in Ca  v   1-  H  mutant – transfected 
cells (  Fig. 7 F  ). This confi  rms that PEST-deleted Ca  v   1-  H  is 
resistant to rapid protein degradation and maintains its integrity 
and physiological function. Furthermore, current-voltage analy-
sis (I-V curves) revealed that neither serum deprivation nor 
PEST-H deletion modifi  es steady-state activation parameters 
(  Fig. S5  ). Also, all electrophysiological experiments were per-
formed at a holding potential of     80 mV, which is a value far 
away from the potential for half steady-state inactivation (V0.5) 
of I  Ca,L , indicating that a change in the macroscopic current prop-
erties of Ca  v  1.2 is unlikely. 
and Ca  v    2-SE mutant but not Ca  v    2-SA mutant completely 
counteracted this reduction (  Fig. 6  ). 
  Akt regulates Ca  v      1 protein stability 
  PEST sequences have been suggested to serve as signals for rapid 
proteolytic degradation through the cell quality control system 
(  Rechsteiner, 1990  ;   Smith et al., 1993  ;   Krappmann et al., 1996  ; 
  Sandoval et al., 2006  ). Notably, PEST-mediated protein degrada-
tion has recently been suggested to play an essential role in mod-
ulating neuronal Ca 
2+   channel function through regulation of the 
Ca  v    3 accessory subunit (  Sandoval et al., 2006  ). Our fi  ndings 
raise the possibility that processing of the Ca  v    1 protein may be 
affected in a similar way. To test this hypothesis, we used the 
web-based algorithm PESTfi  nd (  Rogers et al., 1986  ) in a search 
for potential Ca  v    1 PEST sequences and found several putative 
motifs  (amino  acids  435 – 460,  807 – 820,  847 – 858,  1,732 – 1,745, 
and 1,839 – 1,865). Intriguingly, the highest scored potential PEST 
sequences obtained are highly conserved among species ( Table I ), 
with one located in the I  –  II linker of the Ca  v   1  subunit  and  over-
lapping with the     1-interacting domain (AID), which is the pri-
  Figure 5.       Akt phosphorylation of Ca  v      2 protects Ca  v      1 from protein 
degradation.   (A  –  C) YFP-Ca  v      1  –  cotransfected 293T cells with the indicated 
mutant variant of Ca  v      2. Cells were serum starved overnight and treated 
with 100   μ  M insulin (A and C) or 5   μ  M Akt inhibitor (Akt inh; B) as indi-
cated. The expression of YFP-Ca  v      1 in lysates was monitored by Western 
blot analysis with anti-YFP antibody and normalized based on transfection 
efﬁ  ciency (Ca  v      2) and protein amount (tubulin;   n   = 3). (D) Ca  v      1- and 
Ca  v      2-cotransfected 293T cells were treated with siAkt-expressing vector 
as indicated. 3 d after transfection, cell lysate was tested by Western blot 
analysis. Protein loading was normalized to GAPDH levels. Representative 
experiments are shown (  n   = 3).     929 AKT REGULATES THE CA
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of phosphorylated Akt, the Ca 
2+  current is reduced, resulting in a de-
creased Ca 
2+   transient and contractility. Therefore, it is tempting to 
speculate that the Akt-mediated phosphorylation of Ca  v   2  and  the 
consequent direct association of the Ca  v    2 C-terminal tail with the 
Ca  v    1 C-terminal coiled-coil region (  Fig. 7 E  ) may induce confor-
mational changes that prevent PEST sequences from being recog-
nized by the cell degradation system ( Fig. 8 ). In addition, one cannot 
exclude the possibility that phosphorylated Ca  v    2 might also act in-
directly through other, as of yet unknown, LTCC protein partners. 
 The  identifi  ed mechanism alone is unlikely to be respon-
sible for the detrimental cardiac defects observed in the PDK1 
KO mouse model. To assess whether a reduction in the Akt anti-
apoptotic activity could lead to increased cell death, we mea-
sured caspase 3 activation (Fig. S1). However, consistent with 
previous evidence reported by   Mora et al. (2003)  , our results 
failed to prove any signifi  cant involvement of this mechanism 
in the PDK1 KO phenotype. Our PDK1 KO mouse model does 
not appear to progress through slow transitional states, which 
are typical of heart failure, but rather progresses directly to a 
dilated cardiac phenotype, which eventually leads to premature 
  Collectively, our results suggest that Akt-mediated phos-
phorylation of Ca  v   2  regulates  Ca v    1 density through protection 
of Ca  v    1 PEST motifs from the cell protein degradation machin-
ery. Impairment of this mechanism is expected to result in dys-
regulation of cardiomyocyte contractile function. 
  Discussion 
  This study reveals a mechanism through which the insulin IGF-1  –
 PI3K – PDK1 – Akt  pathway  can  sustain  or  modulate  Ca 
2+   entry  in 
cardiac cells via the voltage-gated LTCC and eventually affect 
cardiac contractility. Using a mouse model with an inducible 
and cardiomyocyte-specifi  c deletion of the upstream activator 
PDK1, we showed that Akt is of key importance for the struc-
tural organization and functionality of the LTCC complex at the 
plasma membrane. This regulation of LTCC activity is directly 
related to the Akt-mediated phosphorylation of the accessory 
subunit Ca  v    2, which in turn results in increased protein density 
of the pore-forming Ca  v    1 subunit through protection of PEST 
sequences from the proteolytic degradation system. In the absence 
  Figure 6.       Akt phosphorylation of Ca  v      2 preserves Ca  v      1 
currents.   Ca 
2+   currents recorded in cotransfected tsA-201 cells with 
YFP-Ca  v      1 and Ca  v      2-WT, Ca  v      2-SE, or Ca  v      2-SA mutant culti-
vated for 36 h in the presence or absence of 10% fetal bovine 
serum. Currents were recorded 1  –  2 min after the whole cell con-
ﬁ  guration was achieved (i.e., after stabilization of the current) 
and were elicited by a 0-mV depolarization of 200-ms duration 
applied from a holding potential of     80 mV. Currents are nor-
malized to cell capacitance (current density, picoampere/pico-
farad). Representative current traces are shown.   n     >   35 at each 
condition (*, P   <   0.05 compared with YFP-Ca  v      1; ANOVA). 
Error bars show SEM.     
  Table I.       PEST sequences are highly conserved in Ca  v      1   
Species Fragment Sequences PESTﬁ  nd score
Mouse PEST I 435-  KGYLDWITQAEDIDPENEDEGMDE  D  K  -460 8.45
Rat PEST I 476-  KGYLDWITQAEDIDPENEDEGMDE  D  K  -501 8.45
Human PEST I 446-  KGYLDWITQAEDIDPENEDEGMDE  E  K  -471 8.66
Mouse PEST II 807-KSITADGESPPTTK-820 9.45
Rat PEST II 848-KSITADGESPPTTK-861 9.45
Mouse PEST III 837-HSNPDTA  GEEDEEEPEMPVGPR  -858 19.51
Rat PEST III 878-HSNPDTA  GEEDEEEPEMPVGPR  -899 19.51
Human PEST II 845-KSPYPNPETT  GEEDEEEPEMPVGPR  -869 20.26
Mouse PEST IV 1,732-KTGNNQADTESPSH-1,745 5.5
Rat PEST IV 1,772-KTGNNQADTESPSH-1,785 5.5
Mouse PEST V 1,839-RMSEEAEYSEPSLLSTDMFSYQEDEH-1,865 5.86
Human PEST IV 1,937-HDTEACSEPSLLSTEMLSYQDDENR-1,961 7.54
Human PEST V 2,214-RGAPSEEELQDSR-2,226 7.71
Occurrence of PEST sites within the amino acid sequence of Ca  v      1 from the mouse, rat, and human. Amino acid identity is underlined.JCB • VOLUME 184 • NUMBER 6 • 2009  930
and change the energy metabolism. Further studies are required 
to unravel the complex mechanisms that contribute to the estab-
lishment of the observed PDK1 KO mouse heart phenotype. 
death (Fig. S1). Therefore, we hypothesize that the lethal pheno-
type is caused by activation of more complex systems that 
rapidly remodel the extracellular matrix and cell to cell contacts 
  Figure 7.       Rapid protein degradation PEST sequences determine Ca  v      1 protein instability.   (A) Schematic representation of Ca  v      1 mapping the AID and PEST 
sequences in the I  –  II and II  –  III cytosolic loops. Deleted PEST sequences (P and H) are highlighted in red. (B) Western blot and immunoﬂ  uorescence analyses 
showing relative levels of WT and PEST-deleted mutants of YFP-Ca  v      1 (  n   = 3). The asterisk indicates a YFP-Ca  v      1 degradation fragment. (C) Half-lives of 
WT Ca  v      1 subunit (alone or cotransfected with Ca  v      2-SE) and its in-frame     PEST mutants (Ca  v      1-    P and Ca  v      1-    H) were determined in COS-7 cells. After 
overnight starvation, transfected cells were pulse chased and analyzed along a time course (*, P   <   0.001 compared with Ca  v      1; ANOVA;   n   = 3). Error bars 
show SD. (D) Western blot and immunoﬂ  uorescence analyses showing relative levels of WT GFP and N-terminal fusion PEST mutants (  n   = 3). (E) The Ca  v      1 
C terminus interacts with the Akt-phosphorylated GST-Ca  v      2 coiled-coil region. Bacterially expressed GST or GST-C-Ca  v      2 (Ca  v      2, amino acids 480  –  655) 
fusion protein and glutathione  –  Sepharose beads were incubated with equal amounts of in vitro  –  translated [ 
35  S]Met-labeled C-Ca  v      1 (Ca  v      1, amino acids 
1,477  –  2,169). Binding occurred only with Akt-phosphorylated GST-C-Ca  v      2. Bound proteins were resolved by SDS-PAGE (4  –  12%). 10% of the input protein 
in each binding reaction is shown. Coomassie staining of SDS-PAGE is shown in the bottom panel. (F) Ca 
2+   currents recorded in tsA-201 cells cotransfected 
with Ca  v      2-WT and either Ca  v      1-WT or Ca  v      1-    H and cultivated for 36 h in the presence or absence of 10% fetal bovine serum. Current densities (pico-
ampere/picofarad) are normalized to the control condition.   n     >   35 at each condition (*, P   <   0.05 compared with Ca  v      1; ANOVA). Error bars show SEM. 
Bars: (B) 5   μ  m; (D) 20   μ  m.     931 AKT REGULATES THE CA
  2+   CHANNEL PROTEIN STABILITY   • Catalucci et al. 
C-terminal region in all Ca  v   2 splice isoforms corroborates the rele-
vance of identifying new functional motifs that may give important 
insights into LTCC modulation. Consistent with an important 
functional role of the conserved Ca  v    2 C-terminal region,   Lao 
et al. (2008)  recently showed that, in the absence of the main Ca  v   2 
protein domain, the selected C-terminal essential determinant is 
suffi  cient for I  Ca,L   stimulation. All together, this evidence supports 
the notion that this region is a potential pharmacological target. 
  In conclusion, we show that the insulin IGF-1  –  PI3K  –
 PDK1 – Akt  pathway  regulates  Ca v    2 chaperone activity through 
phosphorylation by Akt and suggest that, in turn, this controls 
Ca  v    1 channel density by protection of Ca  v   1  from  PEST-
dependent protein degradation (  Fig. 8  ). This paradigm highlights 
an unanticipated regulatory function for Akt in modulating LTCC 
function and provides evidence for an essential role of Akt in the 
control of cardiomyocyte Ca 
2+   handling and contractility. Inter-
estingly, the high level of conservation of PEST sequences in the 
Ca  v    1 subunit throughout evolution (  Table I  ) indicates that our 
proposed mechanism may play a universal role in regulating cell 
Ca 
2+   handling and survival. Because pathophysiological states are 
often accompanied by alterations in LTCC function (  Mukherjee 
and Spinale, 1998  ), the elucidation of this novel regulatory path-
way may open new therapeutic perspectives. 
  Materials and methods 
  Generation of genetically modiﬁ  ed mice 
  Cardiac-speciﬁ   c PDK1-inducible KO mice (MerCreMer     -MHC PDK1) 
were generated by breeding PDK1 
ﬂ  oxed/ﬂ  oxed   Tg mice (provided by D.R. 
Alessi, Medical Research Council Protein Phosphorylation Unit, University 
of Dundee, Dundee, Scotland, UK;   Williams et al., 2000  ) with mice ex-
pressing the cardiac-speciﬁ  c MerCreMer     -MHC promoter-driven   cre   re-
combinase gene (provided by J.D. Molkentin, University of Cincinnati, 
Cincinnati, OH;   Sohal et al., 2001  ). The resulting background strain of the 
MerCreMer mice was C57BL/6-SV129 and was unchanged throughout all 
experiments. Control animals used in this study were PDK1 
ﬂ  oxed/ﬂ  oxed   litter-
mates not expressing the   cre   recombinase gene and were treated with the 
same tamoxifen regiment. Tamoxifen dissolved in maize oil was injected 
intraperitoneally once a day at a dose of 75 mg/kg body weight. Male 
animals 7  –  8-wk old were used. All animal procedures were performed in 
accordance with the Guide for the Care and Use of Laboratory Animals 
and approved by the Institutional Animal Care and Use Committee. 
  Culture and treatment of mouse cardiomyocyte cells 
  Isolation of ventricular myocytes was performed as previously described 
(  Care et al., 2007  ). Cells were infected with an adenovector expressing 
either no transgene (mock), HA  –  E40K-Akt (AdAkt), or Akt-K179M (AdAktDN) 
at MOI 100 and harvested 48 h after infection. The viral vector was ampli-
ﬁ  ed and puriﬁ  ed in 3% sucrose/PBS by ViraQuest, Inc. 
  Cell culture and cDNA mutagenesis 
  Cell transfection was performed in serum-starved medium using Lipofectamine 
2000 (Invitrogen) according to the manufacturer  ’  s instructions. 5   μ  M Akt-XI 
inhibitor (EMD), insulin (Sigma-Aldrich), 1   μ  M baﬁ  lomycin-A1 (Sigma-Aldrich), 
25   μ  M MG132 (EMD), and 25   μ  M calpeptin (EMD) were used as described 
in Results.   Cacnb2   cDNA (complete coding sequence, cDNA clone 
MGC:  129335, IMAGE:40047531; American Type Culture Collection) was 
cloned in the pcDNA3 vector. Site-directed mutagenesis was performed using 
the QuikChange Site-Directed Mutagenesis kit (Agilent Technologies). Ca  v      1 
PEST deletion mutants and GFP fusion proteins were generated by PCR. YFP-
Ca  v      1 expression plasmids were provided by N. Soldatov (National Institute 
on Aging, National Institutes of Health, Baltimore, MD). A lentivirus vector 
was generated and used as an expression vector for siRNA-mediated silenc-
ing of the   akt   gene (siAkt). The sequence used (5    -TGCCCTTCTACAACCAG-
GATT-3    ) was chosen in a conserved region between rat, mouse, and human 
and has been validated for targeting Akt-1 and -2 (  Katome et al., 2003  ). All 
constructs were conﬁ  rmed by DNA sequencing. 
 Several  fi  ndings have shown the importance of the insulin 
IGF-1  –  PI3K  –  Akt pathway in heart function. Our group has pre-
viously demonstrated that overexpression of an active form of 
Akt-1 results in improved cardiac inotropism both in vivo 
( Condorelli et al., 2002 ) and in vitro ( Kim et al., 2003 ), augmenting 
I  Ca,L  . Similar results were recently obtained in a mouse model 
with cardiac-specifi  c Akt-1 nuclear overexpression (  Rota et al., 
2005  ) and in mice defi  cient for PTEN (phosphatase and tensin 
homologue deleted on chromosome 10), an antagonizer of PI3K 
activity (  Sun et al., 2006  ). In addition, short-term administration 
of IGF-1 in animal experiments has also been reported to increase 
cardiac contractility (  Duerr et al., 1995  ). However, the mecha-
nism through which the insulin IGF-1  –  PI3K  –  Akt pathway af-
fects Ca 
2+   current has remained elusive. In an elegant in vitro 
study,  Viard et al. (2004)  demonstrated that a region of the Ca  v   2a 
subunit is involved in the PI3K-induced chaperoning of Ca  v 2.2   
in neurons. This PI3K-induced regulation was shown to be medi-
ated by Akt phosphorylation of the Ca  v    2a subunit, which in turn 
regulates Ca  v 2.2    traffi  cking from the ER to the plasma mem-
brane. Notably, the C-terminal region containing the putative Akt 
phosphorylation consensus site is conserved in all variants of the 
Ca  v    2 subunit both in neurons and the heart (  Viard et al., 2004  ), 
thus illustrating the importance of this site. Interestingly, two very 
short human cardiac splice isoforms, Ca  v    2f and Ca  v   2g,  with 
preserved Akt sites have been shown to be essential for modulat-
ing Ca 
2+   channel function and Ca  v    1 channel density (  De Waard 
et al., 1994  ;   Kobrinsky et al., 2005  ). Strikingly, the same two 
Ca  v    2 variants do not contain the PKA phosphorylation site 
(  Kamp and Hell, 2000  ), which is consistent with our data sug-
gesting no PKA involvement in the modulation of LTCC density 
(Fig. S2 B). As a corollary, the presence of this conserved 
  Figure 8.       Proposed mechanism.   Akt, followed by PDK1 activation, phos-
phorylates Ca  v      2 at the C-terminal coiled-coil domain. The phosphoryla-
tion allows association of the C-terminal portion of Ca  v      2 with the Ca  v      1 
C-terminal domain. In turn, a conformation shift prevents PEST sequence 
recognition, stabilizing Ca  v      1 protein levels. The blue and red ribbons in 
Ca  v      1 represent AID and PEST sequences, respectively.     JCB • VOLUME 184 • NUMBER 6 • 2009  932
sucrose, 1 mM EDTA, 1 mM EGTA, 50 mM NaF, 1 mM Na  3  VO  4  , and prote-
ase inhibitors) and saved as ER fractions. All aliquots were stored at     80  °  C. 
  Histology and confocal microscopy 
  Fixation, staining, and confocal analysis were performed as previously de-
scribed (  Care et al., 2007  ). Confocal microscopy was performed using a 
confocal microscope (Radiance 2000; Bio-Rad Laboratories) with a 60  ×   
Plan-Apochromat NA 1.4 objective (Carl Zeiss, Inc.). Individual images 
(1,024   ×   1,024 pixels) were converted to tiff format and merged as pseudo-
color RGB images using Imaris (Bitplane AG). 
  Pulse-chase and immunoprecipitation experiments 
  36 h after transfection, 293T cells were starved for 30 min in Met- and 
Cys-free DME (Sigma-Aldrich) and were then labeled for 30 min by adding 
500   μ  Ci  
35  S-labeled L-Met and 2 mM L-Cys. Radioactive media was even-
tually washed out with PBS (time 0 pulse) and replaced with normal DME. 
Time points were at 4, 10, and 25 h after pulse. Anti-GFP polyclonal IgG 
(GTX20290) was used for immunoprecipitation. Radioactivity was quanti-
tated with ImageQuant 5.2 software (GE Healthcare). 
  GST pull-down assay 
  Afﬁ  nity-puriﬁ  ed GST fusion proteins were generated using a pGEX system 
(GE Healthcare) and phosphorylated as described below. GST fusion protein 
bound to glutathione  –  Sepharose 4B beads (GE Healthcare) was incubated 
with 25   μ  l of  
35  S-labeled Met protein with moderate shaking at 25  °  C for 2 h 
in 200   μ  l of binding buffer containing 20 mM Hepes, pH 7.9, 1 mM EDTA, 
10% glycerol, 0.15 M KCl, 0.05% Nonidet P-40, and 1 mM DTT.  
35  S-labeled 
probes were generated from the C-terminal region of Ca  v      1 cDNA fragments 
under control of the T7 promoter using the TnT Quick Coupled Reticulocyte 
Lysate System (L1170; Promega), washed three times with washing buffer 
(20 mM Hepes, pH 7.9, 1 mM EDTA, 10% gly  cerol, 250 mM KCl, and 0.1% 
Nonidet P-40), and centrifuged. Bound proteins were eluted in SDS sample 
buffer, subjected to SDS-PAGE, and detected by autoradiography. Recombi-
nant GST-Ca  v      2 beads or GST beads were phosphorylated by incubation 
with recombinant Akt (Millipore). In brief, 5   μ  g GST-Ca  v      2 or GST beads 
were incubated at 30  °  C for 45 min in a 50-  μ  l solution containing 2   μ  g acti-
vated Akt kinase, 10 mM Hepes-KOH, pH 7.5, 50 mM     -glycerophosphate, 
50 mM NaCl, 1 mM dithiothreitol, 10 mM MnCl  2  , and 1 mM ATP. 
  Statistical analysis 
  Statistical comparison was performed within at least three independent ex-
periments by paired or unpaired Student  ’  s   t   test, whereas comparison be-
tween groups was analyzed by one-way repeated-measures analysis of 
variance (ANOVA) combined with a Newman-Keuls post-test to compare 
different values using Prism 4.0 software (GraphPad Software, Inc.). Differ-
ences with P   <   0.05 were considered statistically signiﬁ  cant. 
  Online supplemental material 
  Fig. S1 shows additional biochemical, histological, and echocardiographic 
analyses of mice lacking PDK1 expression. Fig. S2 shows SERCA2 level 
and phosphorylation of speciﬁ  c PKA regulatory sites in two SR Ca 
2+   regula-
tory proteins, Ryr (Ryr2-P2809) and PLN (PLN-P16). Fig. S3 shows repre-
sentative Ca 
2+   traces and twitch Ca 
2+   transient amplitude in KO compared 
with WT cardiomyocytes. Fig. S4 shows coimmunoprecipitation of Ca  v      2 
with insulin-activated Akt isoforms and the effects of dominant-active and 
-negative Akt as well as siAkt on the Ca  v      1 protein level. Fig. S5 shows 
current-voltage analysis (I-V curves) of cells transfected with Ca  v      1-WT or 
Ca  v      1-    H in normal or serum-free conditions. Table S1 shows echocardiog-
raphy analysis values of WT and KO mice. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.200805063/DC1. 
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  Ca 
2+   current measurement 
  Macroscopic I  Ca,L   was recorded at room temperature (    22  °  C) using the 
whole cell patch-clamp technique in native cells as previously described (    Maier 
et al., 2003  ;   Aimond et al., 2005  ). External recording solution contained 
136 mM tetraethylammonium (TEA)-Cl, 2 mM CaCl  2  , 1.8 mM MgCl  2  , 
10 mM Hepes, 5 mM 4-aminopyridine, and 10 mM glucose, pH 7.4, with 
TEA-OH. Pipette solution contained 125 mM CsCl, 20 mM TEA-Cl, 10 mM 
EGTA, 10 mM Hepes, 5 mM phosphocreatine, 5 mM Mg  2  -ATP, and 0.3 GTP, 
pH 7.2, with CsOH. Myocytes were held at     80 mV, and 10-mV depolariz-
ing steps from     50 to 50 mV for 300 ms were applied. Analysis was per-
formed using a microscope (Diaphot 200; Nikon) equipped with 10  ×   NA 20 
objective lenses (CFWN; Nikon). pCLAMP 9 (MDS Analytical Technologies) 
was used as acquisition software. For electro  physiological recordings of re-
combinant Ca  v      1 currents, tsA-201 cells were transfected in OptiMEM (Invit-
rogen) with a DNA mix containing plasmids encoding YFP-Ca  v      1, Ca  v      2 
subunit (either Ca  v      2-WT, Ca  v      2-SE, or Ca  v      2-SA), Ca  v      2    1 subunit, and 
CD8 (in a ratio of 1:2:0.5:0.1). After 24 h, cells were cultured in DME with 
or without serum for 36 h, and electro  physiological recordings were per-
formed on cells expressing both YFP-Ca  v      1 and CD8, which is identiﬁ  ed 
using anti-CD8  –  coated beads (Dynabeads; Invitrogen). The     330-mosM 
extracellular solution contained 135 mM NaCl, 20 mM TEA-Cl, 5 mM CaCl  2  , 
1 MgCl  2  , and 10 mM Hepes (pH adjusted to 7.4 with KOH). Borosilicate 
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an     315-mosM internal solution containing 140 mM CsCl, 10 mM EGTA, 
10 mM Hepes, 3 mM Mg-ATP, 0.6 mM GTP-Na, and 2 mM CaCl  2   (pH 
adjusted to 7.2 with KOH). Analysis was performed using a microscope 
(x71; Olympus). Data acquisition was performed with pCLAMP 9 software. 
  Fluorescent measurement of [Ca 
2+  ]  i   
  Isolated myocytes were loaded with 5   μ  M Fura-PE3 acetoxymethyl (TefLabs) 
and analyzed as previously described (  Bassani et al., 1994  ;   DeSantiago 
et al., 2002  ). Analysis was performed using a Diaphot 200 microscope. 
Data acquisition and analysis were performed using pCLAMP software 
(Clampex and Clampﬁ  t version 8.2; MDS Analytical Technologies). 
  Akt and PKC kinase assay 
  Myocardial tissue lysates were tested using the Akt Kinase Assay kit (Cell 
Signaling Technology) and PKC (Millipore) according to the manufacturer  ’  s 
instructions. 
  Western blot analysis and antibodies 
  Protein expression was evaluated in total lysates or cell fractions by Western 
blot analysis according to standard procedures. Antibodies against the fol-
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dehydrogenase (GAPDH; Cell Signaling Technology). ImageJ software 
(National Institutes of Health) was used to perform densitometry analyses. 
  Tissue preparation, immunoprecipitation, and in vitro phosphorylation 
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idly extracted, freeze clamped in liquid nitrogen, and homogenized to a 
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